Ixekizumab in the Treatment of Bullous Pemphigoid
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2017
At a glance
- Drugs Ixekizumab (Primary)
- Indications Bullous pemphigoid
- Focus Therapeutic Use
- 18 Aug 2017 Status changed from not yet recruiting to recruiting.
- 17 Jul 2017 Planned initiation date changed from 1 Apr 2017 to 1 Aug 2017.
- 07 Apr 2017 New trial record